Pharmacists are part of patient care now, not just the people behind the counter. That raises the bar for training. A PharmD has to prepare you for real clinical work, which makes a fully online path tricky. So what does a distance program actually look like in practice, and what stays hands-on? Pharmacists don’t spend […]
The post Training Pharmacists Today Isn’t Classroom Work Anymore appeared first on Medical News Bulletin.
There is quite a big jump when you move from doing your undergraduate degree to your online master’s in speech pathology. This jump is intentional. The field you’ll be working in is highly rewarding but it is also challenging and any good program or university needs to prepare you for the realities of this occupation. […]
The post The Transition From Undergraduate To Online Master’s Level Study In Speech Pathology And How Clinical Thinking Evolves appeared first on Medical News Bulletin.
Scientists say they have figured out why bitter herbs show up in folk remedies as a digestive aid, and they tell us which ones actually work.
The post Bulletin: Scientists show Bitter Herbs Stimulate Stomach Acid appeared first on Medical News Bulletin.
Glaucoma videos on social media may promote dangerous, unproven treatment options and frequently do not discuss any risks associated with them, according to data published in Clinical Ophthalmology.
“Given the irreversible nature of glaucoma and the importance of vision in quality of life, patients with advanced glaucoma are likely to use online resources to investigate options for glaucoma treatment and/or management,” Soshian Sarrafpour, MD, assistant professor of ophthalmology and visual science at the Yale School of Medicine, and colleagues wrote. “For popular media sites
The FDA has approved an oral combination therapy for certain adults with newly diagnosed acute myeloid leukemia.
Decitabine and cedazuridine tablets (Inqovi, Taiho Oncology) in combination with venetoclax (Venclexta; AbbVie, Genentech) received approval for patients with a new diagnosis of AML aged 75 years or older or with comorbidities that prevent them from intensive induction chemotherapy.
The FDA based its decision on the single-arm, open-label ASTX727-07 study of 101 adults, of whom 42 (41.6%; 95% CI, 31.9-51.8) achieved complete response. The median time to complete response was 2 months
Some patients with dry eye disease can be difficult to treat, but clinicians can help them by looking for underlying issues, according to a speaker at Real World Ophthalmology.
In her presentation, Weijie Violet Lin, MD, provided her general approach to dry eye consultation and helping patients resolve this disruptive condition.
“We've all seen these patients that come in with itching, burning, stinging and tearing,” she said. “It's everywhere.”
The first thing Lin wants to know is when the dry eye symptoms are most prominent. The answer could reveal what is causing the problem, she said.
“Is it
Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials published in The New England Journal of Medicine.
Although the trials — one conducted in the United Kingdom (PANORAMIC) and the other in Canada (CanTreatCOVID) — determined that Paxlovid (nirmatrelvir-ritonavir, Pfizer) does not reduce the incidence of hospitalization or death among vaccinated high-risk patients with SARS-CoV-2 compared with usual care, the combination medication sped up recovery in a meaningful way, experts noted.
Nirmatrelvir-ritonavir is an antiviral regimen
Polyendocrine metabolic ovarian syndrome, or PMOS, is the new name for polycystic ovary syndrome, or PCOS, following a global initiative to correct the condition’s terminology.
One in eight women globally — or about 170 million — are affected by PMOS, according to a health policy paper published in The Lancet that announced the name change.
But the previous term was inaccurate, Helena Teede, AM, PhD, MBBS, FRACP, FRANZCOG, FRCOG, FAAHMS, director of Monash Centre for Health Research and Implementation, and colleagues wrote. It implied pathological ovarian cysts and obscured the various
A standard dose of ivermectin combined with 5% permethrin was superior to higher-dose ivermectin for the treatment of severe scabies, according to a study published in The New England Journal of Medicine.
Results showed that 75% of participants who received the higher dose of ivermectin with 5% permethrin were cured of the parasitic infection vs. 82% in the standard-dose group.
“The hypothesis was that the higher dose of oral ivermectin might provide a greater efficacy than the standard dose, as demonstrated in those with difficult-to-treat head lice,” Olivier Chosidow, MD, PhD, a dermatologist
The challenges of health care have led many physicians to consider changing their professional environment. The first impulse is to modify the current situation, but systemic and institutional inertia may prevent any meaningful change.
Questions arise and these concerns may be briefly silenced by strong clinical outcomes, patient gratitude or the rewards of mentoring fellows and residents who value your guidance. However, for an increasing number of physicians at every stage of a career, the introspective voices may be growing louder, leading one to question if status quo is still acceptable